In this phase 3 trial, researchers aimed to study the efficacy of tumor bed boost and moderately hypofractionated whole breast irradiation in patients with non-low-risk DCIS.

Clinical research technology veteran joins to accelerate company's growth as the unified platform solution for ...

A new Divinity AMA with developer Larian Studios discusses use of generative-AI tools in development, lessons from BG3, and ...

H-2B program is used by American companies to hire foreign nationals for temporary non-agricultural occupations in the United ...

Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential ...

In the end randomization did not save us much time.” Larian will continue iterating on its existing Divinity Engine for the next game. It’s not suddenly moving to Unreal like some other RPG studios.

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...

The goal of Herringen isn't just to take out the fortress but to do it as riskily as possible to earn the best ranking.

A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...